tirzepatide obstructive sleep apnea fda approval 2024 🚨 BREAKING: A New Era for Treatment! 🚨, For the first time ever, the has approved Zepbound (tirzepatide) to treat sleep apnea (OSA) in adults with obesity!, 🌙 Clinical FDA approves weight-loss drug Zepbound

We explored what responsible-AI means in clinical contexts: from realistic threat models (with evidences) and jailbreak scenarios to aligning systems with general & clinical values alongside establishing practical guardrails through evaluation, red-teaming, documentation, and governance

We look forward to helping you explore how these heart-protective benefits might improve your overall cardiovascular health

PMID: 97 EmensLADavidsonNE

Obesity paradox in acute respiratory distress syndrome among patients undergoing cardiac surgery: a retrospective study

10.1038/s41591-018-0104-9 17 FruciB.GiulianoS.MazzaA.MalaguarneraR.BelfioreA